Juan Martinez
Stories (98)
Filter by community
US Remote Patient Monitoring Market Surges to $29.13 Billion by 2030. AI-Generated.
The Remote Patient Monitoring (RPM) market in the United States is evolving rapidly, becoming a fundamental element of contemporary healthcare systems and a key focus for healthcare leaders across the country. The market was worth $14.15 billion in 2024 and is expected to grow to $16.09 billion in 2025. Forecasts indicate a strong compound annual growth rate (CAGR) of 12.6% until 2030, with a total market value of $29.13 billion anticipated by the close of the decade.
By Juan Martinez5 days ago in Futurism
North America Next-Generation Sequencing Market Poised to Double to $11.63 Billion by 2030. AI-Generated.
The North American next-generation sequencing (NGS) market is entering a transformative growth phase, advancing from $6.15 billion in 2025 to a projected $11.63 billion by 2030, representing a compound annual growth rate (CAGR) of 13.6%. This acceleration signals a fundamental shift in how healthcare systems, biopharmaceutical enterprises, and research institutions approach disease diagnosis, drug development, and patient stratification.
By Juan Martinez5 days ago in Futurism
US Pharmaceutical Drug Delivery Market Poised to Reach $1.24 Billion by 2031. AI-Generated.
The United States pharmaceutical drug delivery market is entering a transformative growth phase, with valuations climbing from $910 million in 2025 to a projected $1.24 billion by 2031, representing a robust compound annual growth rate (CAGR) of 5.8%. This expansion signals a fundamental recalibration of how therapeutics reach patients, driven by the convergence of advanced biologics, digital health integration, and patient-centric delivery innovations that are redefining treatment paradigms across oncology, diabetes, and autoimmune disease management.
By Juan Martinez6 days ago in Futurism
Global Human Microbiome Manufacturing Services Market Poised to Triple by 2031, Reaching $270 Million as Live Biotherapeutics Revolution Accelerates. AI-Generated.
The global human microbiome manufacturing services market is entering a transformative growth phase, advancing from $110 million in 2025 to a projected $270 million by 2031, representing a compelling CAGR of 16.7%. This expansion reflects a fundamental shift in how pharmaceutical and biotechnology companies approach live biotherapeutic product (LBP) development, as specialized manufacturing capabilities become essential for bringing next-generation microbial therapeutics from clinical trials to commercial reality.
By Juan Martinez6 days ago in Futurism
Europe Pen Needles Market Poised for Steady Expansion, Reaching US$1.10 Billion by 2031 Amid Diabetes Growth and Home-Care Shift. AI-Generated.
Europe’s pen needles market is entering a period of sustained, value-driven growth as chronic disease burden, demographic shifts, and home-based care adoption reshape injectable therapy delivery across the region. Valued at US$0.66 billion in 2025, the market increased to US$0.72 billion in 2026 and is projected to expand at a resilient CAGR of 8.9% from 2026 to 2031, reaching a forecasted US$1.10 billion by 2031.
By Juan Martinez6 days ago in Futurism
Europe AI in Healthcare Market Set to Surge Toward USD 31.72 Billion by 2030 as Regulation, Cloud Adoption, and Clinical AI Accelerate. AI-Generated.
Europe’s Artificial Intelligence (AI) in Healthcare market is entering a decisive growth phase, as regulatory clarity, cloud-scale infrastructure, and AI-enabled clinical transformation converge to reshape healthcare delivery across the region. Valued at USD 4.20 billion in 2024, the market expanded to USD 6.12 billion in 2025 and is projected to grow at a robust CAGR of 39.0% from 2025 to 2030, reaching an estimated USD 31.72 billion by 2030.
By Juan Martinez6 days ago in Futurism
U.S. Pen Needles Market on Track to Reach USD 1.53 Billion by 2031 as Home-Based Diabetes Care and Device Innovation Accelerate. AI-Generated.
The U.S. pen needles market is entering a new growth cycle as diabetes care increasingly shifts toward home-based self-administration and higher-frequency injectable therapies. Valued at USD 0.85 billion in 2025 and USD 0.93 billion in 2026, the market is projected to expand at a CAGR of 10.4% from 2026 to 2031, reaching USD 1.53 billion by the end of the forecast period. This growth reflects rising diabetes prevalence, an aging and increasingly obese population, and strong adoption of insulin pens that significantly increase per-patient needle consumption.
By Juan Martinez6 days ago in Futurism
Europe Remote Patient Monitoring Market Set to Surpass USD 11.22 Billion by 2030 as Virtual Care Becomes Central to Healthcare Transformation. AI-Generated.
The Europe Remote Patient Monitoring (RPM) market is entering a decisive phase of expansion as healthcare systems pivot toward preventive, community-based, and digitally enabled care models. Valued at USD 6.87 billion in 2025, the market is projected to reach USD 11.22 billion by 2030, growing at a CAGR of 10.3% from 2025 to 2030. This growth reflects rising investment in home-based care, strengthening cross-border digital health infrastructure, and increasing demand from providers for real-time patient data to enable early intervention, reduce readmissions, and ensure continuity of care across decentralized settings.
By Juan Martinez6 days ago in Futurism
Europe Human Microbiome Market Poised for Exponential Growth as Precision Health and Advanced Therapeutics Gain Strategic Momentum. AI-Generated.
The Europe Human Microbiome Market is entering a decisive growth phase, driven by accelerating demand for personalized healthcare, rapid advances in sequencing technologies, and expanding clinical validation of microbiome-based therapeutics. Valued at US$0.22 billion in 2024 and reaching US$0.29 billion in 2025, the market is projected to grow at a robust CAGR of 28.6% from 2025 to 2031, achieving a forecasted valuation of US$1.31 billion by 2031.
By Juan Martinez6 days ago in Futurism
Asia Pacific In Vitro Diagnostics Market Poised for Sustained Expansion, Projected to Reach USD 45.11 Billion by 2031. AI-Generated.
The Asia Pacific in vitro diagnostics (IVD) market is entering a decisive growth phase, underscoring its strategic importance for healthcare leaders, diagnostics manufacturers, and investors worldwide. Valued at an estimated USD 29.27 billion in 2026, the market is projected to reach USD 45.11 billion by 2031, expanding at a robust CAGR of 9.0% during the forecast period.
By Juan Martinez11 days ago in Futurism
North America Human Microbiome Market Set to Surge at 32.2% CAGR, Reaching USD 4.15 Billion by 2031. AI-Generated.
The North America human microbiome market is entering a decisive growth phase as healthcare systems, biotechnology leaders, and research institutions accelerate investments in next-generation, microbiome-based solutions. Valued at USD 0.43 billion in 2024 and rising sharply to USD 0.78 billion in 2025, the market is projected to expand at a robust CAGR of 32.2% from 2025 to 2031, reaching an estimated USD 4.15 billion by the end of the forecast period.
By Juan Martinez11 days ago in Futurism
Europe Pharmaceutical Drug Delivery Market to Reach USD 703.19 Billion by 2031. AI-Generated.
The Europe pharmaceutical drug delivery market is entering a decisive growth phase, reflecting how healthcare systems, pharmaceutical leaders, and device manufacturers are rethinking how medicines are administered, experienced, and scaled across diverse patient populations.
By Juan Martinez11 days ago in Futurism
